LGW16-03
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for LGW16-03, covering 2026-03-18 to 2026-03-18. Get the full timeline:
Most recent: Clinical Trial Update: Study of LGW16-03 To Identify Nerves [Phase 1]